Edwards Lifesciences Corp Revenue and Competitors
Estimated Revenue & Valuation
- Edwards Lifesciences Corp's estimated annual revenue is currently $5.1B per year.
- Edwards Lifesciences Corp's estimated revenue per employee is $320,065
- Edwards Lifesciences Corp's current valuation is $73.8B. (January 2022)
Employee Data
- Edwards Lifesciences Corp has 15903 Employees.
- Edwards Lifesciences Corp grew their employee count by 7% last year.
Edwards Lifesciences Corp's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Enterprise Architect | Reveal Email/Phone |
2 | Chief Scientific Officer & Corporate VP | Reveal Email/Phone |
3 | TMTT VP and Japan Business Unit Head | Reveal Email/Phone |
4 | VP | Reveal Email/Phone |
5 | Executive Assistant to the VP, TMTT Global Marketing and the VP, Strategy | Reveal Email/Phone |
6 | Area VP, THV | Reveal Email/Phone |
7 | Sr. VP, Japan Asia Pacific Region Finance | Reveal Email/Phone |
8 | Chief Operating Officer | Reveal Email/Phone |
9 | Chief Scientific Officer & Corporate VP | Reveal Email/Phone |
10 | VP | Reveal Email/Phone |
Edwards Lifesciences Corp Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $68.5M | 273 | N/A | N/A | N/A |
What Is Edwards Lifesciences Corp?
Edwards Lifesciences Corp provides a comprehensive line of products and services to treat late-stage cardiovascular disease. The Company's sales are categorized in four main product areas: cardiac surgery, critical care, vascular, and perfusion products and services. Edwards Lifesciences, which is headquartered in Irvine, California, supplies its products and services to customers in more than 80 countries, both through direct sales and distributor relationships.
keywords:N/AN/A
Total Funding
15903
Number of Employees
$5.1B
Revenue (est)
7%
Employee Growth %
$73.8B
Valuation
N/A
Accelerator
Edwards Lifesciences Corp News
Shares of Edwards Lifesciences Corp. EW, -0.03% sank 0.03% to $109.77 Thursday, on what proved to be an all-around positive trading session for...
Shares of Edwards Lifesciences Corp. EW, -1.17% slipped 5.56% to $109.80 Wednesday, on what proved to be an all-around favorable trading...
(AP) _ Edwards Lifesciences Corp. (EW) on Tuesday reported first-quarter net income of $373.6 million. On a per-share basis, the Irvine,...
Edwards Lifesciences (NYSE: EW) reported third-quarter financial results that exceeded Wall Street’s expectations on profits but narrowly missed on sales. The Irvine, California–based cardio device company yesterday evening reported earnings of $340.1 million (or 54¢ per share) off sales of $1. ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6131.2M | 16220 | 3% | N/A |
#2 | $5100.8M | 25127 | N/A | N/A |
#3 | $5914.2M | 28523 | 0% | N/A |
#4 | $3420M | 31833 | 3% | N/A |
#5 | $16215.7M | 46146 | N/A | N/A |